The faculty of two institutions, Weill Cornell Medical College (WCMC) and Memorial Sloan-Kettering Cancer Center (MSKCC), are requesting funds to support a collaborative training program in research in the area of cancer pharmacology. The collaboration consists of an integrated set of training activities for Ph.D. students and postdoctoral fellows. The strength and diversity of the 16 faculty provide opportunities for research in a variety of different areas, such as the development of new cancer therapeutic agents (e.g. through organic synthesis, monoclonal antibody technology, differentiation therapy, and the screening of new compounds), and the analysis of molecular mechanisms by which drugs act on cancer cells. Additionally, research concerning the mechanisms by which dioxin and environmental pollutants cause cancer is a part of the training program. Training program faculty research includes basic, mechanistic studies of the molecular actions of drugs used in cancer treatment and prevention, and research leading to more clinical endpoints. The graduate Ph.D. program consists of course work and three laboratory rotations, followed by an admission to candidacy exam and thesis research. A graduate course in Cancer Pharmacology is part of this program and represents a commitment of the faculty to the training of students in this area. Students and fellows present their research at the annual two-day Pharmacology Program retreat. Postdoctoral fellows attend a weekly journal club, take courses in cancer pharmacology, and present a formal seminar in the cancer pharmacology seminar series. It is expected that this training program will provide students and fellows with a broader understanding of the interrelationships between research on the basic mechanisms of drug action and drug development and clinical issues so that both clinicians and basic scientists will be better prepared to carry out research to prevent or treat cancer. Our request for continued NIH support of a training program in Cancer Pharmacology builds on major commitments of the participating institutions to the enhancement of research in this area. The faculty of this training program are members of the joint WCMC/SKI graduate program, with a total of 31 Pharmacology Ph.D. Program faculty. Thus, this faculty represents a cohesive, interactive group with a common interest in research and training in the area of cancer pharmacology.

Public Health Relevance

This Training program is unusual in several respects. First, this is one of the few training programs focused specifically on cancer pharmacology. Second, this training program features cancer research training in molecular pharmacology, animal models of cancer, and human clinical trials research. Many of the faculty are physician-scientists who treat patients as well as perform research. Third, this group of faculty is very collaborative. All of these features make this program extremely relevant and useful for training the next generation of cancer pharmacology researchers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee B - Comprehensiveness (NCI)
Program Officer
Lim, Susan E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Weill Medical College of Cornell University
Schools of Medicine
New York
United States
Zip Code
Galassi, Thomas V; Jena, Prakrit V; Roxbury, Daniel et al. (2017) Single Nanotube Spectral Imaging To Determine Molar Concentrations of Isolated Carbon Nanotube Species. Anal Chem 89:1073-1077
Mauer, Jan; Luo, Xiaobing; Blanjoie, Alexandre et al. (2017) Reversible methylation of m6Am in the 5' cap controls mRNA stability. Nature 541:371-375
Olarerin-George, Anthony O; Jaffrey, Samie R (2017) MetaPlotR: a Perl/R pipeline for plotting metagenes of nucleotide modifications and other transcriptomic sites. Bioinformatics 33:1563-1564
Levinson, Adam M; McGee, John H; Roberts, Andrew G et al. (2017) Total Chemical Synthesis and Folding of All-l and All-d Variants of Oncogenic KRas(G12V). J Am Chem Soc 139:7632-7639
Brooks, Joshua L; Xu, Liping; Wiest, Olaf et al. (2017) Diastereoselective Synthesis of Highly Substituted Tetrahydrofurans by Pd-Catalyzed Tandem Oxidative Cyclization-Redox Relay Reactions Controlled by Intramolecular Hydrogen Bonding. J Org Chem 82:57-75
Grozhik, Anya V; Linder, Bastian; Olarerin-George, Anthony O et al. (2017) Mapping m6A at Individual-Nucleotide Resolution Using Crosslinking and Immunoprecipitation (miCLIP). Methods Mol Biol 1562:55-78
Verano, Alyssa L; Tan, Derek S (2017) Stereocontrolled Synthesis of Spiroketals: An Engine for Chemical and Biological Discovery. Isr J Chem 57:279-291
Vu, Ly P; Pickering, Brian F; Cheng, Yuanming et al. (2017) The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med 23:1369-1376
Jena, Prakrit V; Roxbury, Daniel; Galassi, Thomas V et al. (2017) A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux. ACS Nano 11:10689-10703
Dao, Tao; Korontsvit, Tatyana; Zakhaleva, Victoria et al. (2017) An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules. Oncoimmunology 6:e1252895

Showing the most recent 10 out of 140 publications